Sputnik V vaccine: Russia’s Sputnik vaccine will be available in the market from next week, the government announced

New Delhi: The situation has worsened in India as the number of new corona patients is increasing. Vaccines are in short supply in many states. This has also hampered the vaccination of citizens between the ages of 18 and 44. Against this backdrop, the central government has taken a big decision. Russia’s Sputnik V vaccine will be available in the country from next week.

From next week, citizens will be able to get a dose of Russia’s Sputnik vaccine. The vaccine will go into production in India from July. The Sputnik vaccine has been introduced in India. The vaccine will be available in the market next week. Russia’s limited sales of the vaccine will begin next week, said a member of the policy commission. V. K. Given by Paul.

‘Many foreign vaccines to come to India’

The government is working at every level to make more vaccines available in the country. A total of 216 crore doses are expected to be available from August to December. Out of this, 55 crore doses will be available for Covacin, 75 crore for Covishield, 30 crore for Bio-E sub unit vaccine, 50 crore for Zydus Cadilla DNA, 20 crore for Nova vaccine, 100 crore for Bharat Biotech’s nasal vaccine, 6 crore for Genova and 15 crore for Putinik vaccine. Apart from this, other foreign vaccines can also be approved, said Dr. V. K. Given by Paul.

Covaxin Trial: DCGI approves covaxin trial for 2-18 year olds

Will the covacin vaccine formula be offered to other companies?

Vaccination of all citizens above 18 years of age has been approved in the country. This population is 95 crores. A total of 2 billion doses are required for all these vaccinations. The vaccines that are coming in are enough, Paul said. Will the covacin vaccine formula be offered to other companies? That was the question Paul was asked. The company has welcomed the demand. Not only this, the government has also held discussions with other companies. This vaccine kills the live virus. This means that the vaccine can only be given in a BSL three level lab. This lab is not owned by any other company. “Any company that wants to set up such a lab to produce vaccines has an open offer,” he said. V. K. Paul explained.

covid 19 india: Corona dies after giving birth to baby doctor, working without maternity leave

‘Any vaccine approved by WHO can come to India’

States needed flexibility in vaccination policy. There was a demand for vaccines to be available in the private sector as well. This has led to a new strategy for the third phase of vaccination. Any vaccine approved by WHO and FDA can be brought to India. The vaccine import license will be issued in two days. Also, no license is pending for vaccine import. The number of citizens in the country over the age of 45 is 34 crores. One-third of these citizens have taken the first dose of the vaccine. That means one in three people have taken the dose of the vaccine. V. K. Given by Paul.